State Street Corporation 13D and 13G filings for Enanta Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-22 12:25 pm Sale |
2023-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
STATE STREET CORP STT |
425,640 2.020% |
-1,086,552 (-71.85%) |
Filing |
| 2023-02-08 1:17 pm Purchase |
2022-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
STATE STREET CORP STT |
1,512,192 7.270% |
385,123 (+34.17%) |
Filing |
| 2022-02-11 11:11 am Sale |
2021-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
STATE STREET CORP STT |
1,127,069 5.550% |
-46,171 (-3.94%) |
Filing |
| 2021-02-09 12:33 pm Purchase |
2020-12-31 | 13G | Enanta Pharmaceuticals, Inc. ENTA |
STATE STREET CORP STT |
1,173,240 5.840% |
1,173,240 (New Position) |
Filing |